相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
H. Jenkins et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
K. Ashida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
Yuuichi Sakurai et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2015)
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
Hashem B. El-Serag et al.
GUT (2014)
New and Future Drug Development for Gastroesophageal Reflux Disease
Carla Maradey-Romero et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Gastroesophageal reflux disease: Update on inflammation and symptom perception
Annamaria Altomare et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment
Ronnie Fass
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Burden of Gastrointestinal Disease in the United States: 2012 Update
Anne F. Peery et al.
GASTROENTEROLOGY (2012)
A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands
Jun Matsukawa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
Yasunobu Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438)
Jai Moo Shin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases
Yasunobu Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis
Peter J. Kahrilas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases
K Andersson et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Epidemiology of gastrooesophageal reflux disease: A systematic review
J Dent et al.
GUT (2005)
Short-term treatment of gastroesophageal reflux disease - A systematic review and meta-analysis of the effect of acid-suppressant drugs in empirical treatment and in endoscopy-negative patients
B van Pinxteren et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
分享论文
